BEAT
HeartBeam, Inc.
Set alert
0.55 USD +0.01 +2.06%
0.52 Day range 0.5589
0.36 52-week range 3.44
- YTD
- -77.08%
- 1 year
- -65.84%
- Open
- 0.54
- Prev close
- 0.5389
- Mkt cap
- 30.99M
- Vol
- 1.70M
- Avg vol
- 7.39M
- EPS
- -0.50
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.52
- High
- 0.5589
- Forward P/E
- -4.51
- Beta
- -0.99
- Short ratio
- 1.64
- Inst. own
- 8.73%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.59
- 200-d avg
- 2.39
- 1y target
- 5.00
Key statistics
- Market cap
- 63.73M
- Enterprise value
- 52.73M
- Trailing P/E
- 0.00
- Forward P/E
- -4.51
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 3.95
- EPS (TTM)
- -0.68
- Beta
- -0.99
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -6.47M
- Total cash
- 9.16M
- Total debt
- 0
- Return on equity
- -113.62%
- Shares outstanding
- 26.67M
- Short % of float
- 0.58%
- 50-day average
- 2.59
- 200-day average
- 2.39
Analyst view
Consensus: buy
Buy
Price target (mean) 5.00 +809.1% upside
Now 0.55
- Target (low)
- 2.00
- Target (mean)
- 5.00
- Target (high)
- 8.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
BEAT Revenue — quarterly 0
BEAT Net income — quarterly -5.04M
BEAT EPS — quarterly -0.10
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | 0.00 | -0.19 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.19 | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.00 | -0.17 | — | — |
| Mar 20, 2024 | Dec 1, 2023 | -0.12 | -0.13 | -0.01 | -8.33% |
| Nov 14, 2023 | Sep 1, 2023 | -0.12 | -0.13 | -0.01 | -8.33% |
| Aug 10, 2023 | Jun 1, 2023 | -0.10 | -0.16 | -0.06 | -60.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 15, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| May 13, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Mar 25, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Nov 16, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Aug 24, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| May 19, 2023 | Alliance Global Partners | main | Buy | Buy |
About HeartBeam, Inc.
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- heartbeam.com
News
- HeartBeam to Present Results of ALIGN-ACS Study for Heart Attack Assessment at TCT 2026 on November 1, 2026
- HeartBeam Wins FDA Total Product Life Cycle Advisory Program Pilot Acceptance For Heart Attack Assessment Technology
- HeartBeam Completes Enrollment Ahead Of Schedule In 486-Patient HEADSTART-ACS Study
- HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
- HeartBeam Named Contributing Partner In Launch Of EXIT-CVD Research Project, Co-Funded By European Union Innovative Health Initiative And Industry Partners
- HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System
- HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System
- 12 Health Care Stocks Moving In Monday's Intraday Session
Your note
Sign in to keep a note on BEAT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROUNSTEIN RICHARD D | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 9, 2023 | 112,108 |
| DE URIOSTE GEORGE A. | Director | Sale | Sep 5, 2024 | 57,146 |
| ELFRINK WILLHEM P. | Director | Stock Award(Grant) | Jun 11, 2024 | 424,807 |
| FERRARI RICHARD M | Director | Stock Award(Grant) | Jun 11, 2024 | 215,377 |
| JAFF MICHAEL R. | Director | Stock Award(Grant) | Jun 11, 2024 | 75,120 |
| NELSON KENNETH WARWICK III | Director | Stock Award(Grant) | Jun 11, 2024 | 127,147 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 2.82% | 750,714 | 1.79M | Sep 29, 2024 |
| Smith Salley Wealth Management | 0.94% | 250,000 | 597.50K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.88% | 233,397 | 557.82K | Sep 29, 2024 |
| UBS Group AG | 0.60% | 160,002 | 382.40K | Sep 29, 2024 |
| Ritholtz Wealth Management | 0.52% | 139,182 | 332.64K | Sep 29, 2024 |
| O'Shaughnessy Asset Management LLC | 0.52% | 139,182 | 332.64K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.01% | 537,089 | 1.28M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.75% | 200,317 | 478.76K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.47% | 126,136 | 301.46K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.17% | 46,455 | 111.03K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.14% | 38,600 | 92.25K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 30,072 | 71.87K | Oct 30, 2024 |